Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-09-07

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company. This action updates the approved product through a supplement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humalog (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)